Immediate Impact
55 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2025 Standout
Works of Yanbing Huang being referenced
Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Yanbing Huang | 186 | 16 | 25 | 181 | 73 | 24 | 401 | |
| Wenting Peng | 232 | 8 | 15 | 135 | 51 | 23 | 377 | |
| Chen-Yu Hu | 199 | 1 | 5 | 120 | 37 | 18 | 348 | |
| Zhen Cai | 173 | 3 | 13 | 214 | 62 | 17 | 418 | |
| Tianpei Guan | 84 | 50 | 39 | 67 | 20 | 357 | ||
| Enqi Qiao | 193 | 1 | 28 | 141 | 60 | 24 | 447 | |
| Magdalena Bieniasz | 218 | 1 | 10 | 81 | 48 | 23 | 402 | |
| Huifang Huang | 144 | 10 | 18 | 56 | 27 | 36 | 340 | |
| Yan Xu | 173 | 1 | 8 | 105 | 26 | 17 | 385 | |
| Aušra Sasnauskienė | 196 | 20 | 89 | 72 | 23 | 358 | ||
| Jordi Gonzalez‐Molina | 127 | 1 | 13 | 74 | 52 | 16 | 387 |
All Works
Loading papers...